,

Difficult Decisions in Hepatobiliary and Pancreatic Surgery

An Evidence-Based Approach

Specificaties
Paperback, blz. | Engels
Springer International Publishing | e druk, 2018
ISBN13: 9783319801223
Rubricering
Springer International Publishing e druk, 2018 9783319801223
Verwachte levertijd ongeveer 9 werkdagen

Samenvatting

This book is part of a series covering surgical specialties.  The volumes are multi-authored, containing brief chapters, each of which are devoted to one or two specific questions or decisions within that specialty that are difficult or controversial.  The volumes are intended as a current and timely reference source for practicing surgeons, surgeons in training, and educators that describe the recommended ideal approach, rather than customary care, in selected clinical situations.

Specificaties

ISBN13:9783319801223
Taal:Engels
Bindwijze:paperback
Uitgever:Springer International Publishing

Inhoudsopgave

<p>Chapter 1: Finding and appraising the evidence: EBM and GRADE</p>

<p>Chapter 2: Is Surgery Indicated for Asymptomatic Giant Hepatic Hemangioma?</p>

<p>Chapter 3: What is the Best Surgical Method of Addressing Hepatic Hemangiomas?</p>

<p>Chapter 4: Which Diagnostic Modality is Best to Assess Benign Hepatic Tumors?</p>

<p>Chapter 5: Cystic Diseases of the Liver</p>

<p>Chapter 6: When Should You Operate on Major Hepatic Trauma?</p>

<p>Chapter 7: Surgical Treatment of Hepatocellular Carcinoma: Resection versus Transplantation<br></p>

<p>Chapter 8: Hepatic Epithelioid Hemangioendothelioma</p>

<p>Chapter 9: What is the Best Way to Screen Cirrhotic Patients for Hepatocellular Carcinoma in the United States?</p>

<p>Chapter 10: When is Laparoscopic Liver Resection Preferred Over Open Resection?</p>

<p>Chapter 11: Clinical Management of Pyogenic Liver Abscesses&nbsp;</p>

<p>Chapter 12: Which is better local therapy for HCC, RFA or TACE?</p>

<p>Chapter 13: When should patients withliver metastases from colorectal cancer receive chemotherapy?&nbsp;<br></p>

<p>Chapter 14: What is the best way to assess hepatic reserve prior to liver resection in the cirrhotic patient?</p>

<p>Chapter 15: Treatment Protocols for Small Hepatocellular Carcinoma (≤ 3cm): RFA or Resection?</p>

<p>Chapter 16: Which is the Better Predictor of Hepatic Reserve Prior to Liver Resection:&nbsp; MELD or the Child-Pugh Score?</p>

<p>Chapter 17: Early (&lt;24 hr) or Delayed Cholecystectomy for Acute Cholecystitis?</p>

<p>Chapter 18: Primary Closure or T-tube Drainage after Open or Laparoscopic Common Bile Duct Exploration?</p>

<p>Chapter 19: Single-Incision or Multiport Laparoscopic Cholecystectomy</p>

<p>Chapter 20: Management of Recurrent Cholangitis</p>

<p>Chapter 21: Management of postoperative bile duct stricture&nbsp;</p>

<p>Chapter 22: Immediate or Delayed Repair for Bile Duct Injury Recognized Postoperatively?</p>

<p>Chapter 23: Management of Suspected Choledocholithiasis on Intraoperative Cholangiography</p>

<p>Chapter 24: Management of Incidentally Discovered Gallbladder Cancer</p>

<p>Chapter 25: Gallstone Ileus</p>

<p>Chapter 26: Surgery or Endoscopy for Bile Duct Strictures secondary to Chronic Pancreatitis?</p>

<p>Chapter 27: Routine or Selective Cholangiography for Elective Laparoscopic Cholecystectomy?&nbsp;</p>

<p>Chapter 28: When is bile duct resection indicated for biliary strictures in primary sclerosing cholangitis?</p>

<p>Chapter 29: Assessment of Bile Duct Tumors: Endoscopic vs Radiographic</p>

<p>Chapter 30: Management of Significant Hemobilia: Hepatic Artery Embolization or Stenting?</p>

<p>Chapter 31: The assessment of ductal margin in curative-intent surgery for perihilar Cholangiocarcinoma</p>

<p>Chapter 32: Management of early post-transplant portal vein thrombosis: results of interventional techniques versus surgical</p>

<p>Chapter 33: When should patients with bleeding esophageal varices undergo TIPS versus endoscopic therapy?</p>

<p>Chapter 34: Management of symptomatic portal hypertension: TIPS vs. medical management</p>

<p>Chapter 35: Should all hepatic arteriovenous fistulas be embolized?</p>

<p>Chapter 36: Early or Delayed Cholecystectomy in Acute Gallstone Pancreatitis</p>

<p>Chapter 37: Nutritional Support in Acute Necrotizing Pancreatitis</p>

<p>Chapter 38: Management of Symptomatic Pancreatic Pseudocyst&nbsp;</p>

<p>Chapter 39: Antibiotic Prophylaxis for Acute Necrotizing Pancreatitis</p>

<p>Chapter 40: Endoscopic or Minimally Invasive Debridement of Walled-off Pancreatic Necrosis?</p>

<p>Chapter 41: Surgical Debridement in Necrotizing Pancreatitis</p>

<p>Chapter 42: Surgery or Endotherapy for Large Duct Chronic Pancreatitis</p>

Chapter 43: Pancreatic Head Resection for Painful Chronic Pancreatitis<p></p>

<p>Chapter 44: Is total pancreatectomy with islet autotransplantation indicated in hereditary/genetic pancreatitis?</p>

<p>Chapter 45:&nbsp; Management of Blunt Pancreatic Trauma in Children</p>

<p>Chapter 46: Surgery or Surveillance for Asymptomatic Small Mucinous Pancreatic Head Cyst</p>

<p>Chapter 47: Management of Asymptomatic IPMN in the Elderly</p>

<p>Chapter 48: Minimally Invasive Surgery for Pancreatic Head Cancer</p>

<p>Chapter 49: Advanced Pancreatic Cancer Discovered at Operation: The Role of Palliative Bypass</p>

<p>Chapter 50: Neoadjuvant Therapy for Borderline Resectable Pancreatic Head Cancer</p>

<p>Chapter 51: Neoadjuvant Therapy for Resectable Pancreatic Adenocarcinoma</p>

<p>Chapter 52: Management of borderline resectable pancreatic cancer</p>

<p>Chapter 53: Peritoneal Drain Placement at Pancreatoduodenectomy</p>

<p>Chapter 54: Management of Villous Adenoma of the Ampulla of Vater</p>

<p>Chapter 55: Splenic Preservation at Distal Pancreatectomy</p>

<p>Chapter 56: Management of Small Nonfunctional Pancreatic Neuroendocrine Tumors</p>

<p>Chapter 57: Management of Pancreatic Gastrinoma</p>

<p>Chapter 58: Management of Pancreatic Cancer in the Elderly</p>

Rubrieken

    Personen

      Trefwoorden

        Difficult Decisions in Hepatobiliary and Pancreatic Surgery